HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gays, F. Articles by Brooks, C. G. Search for Related Content PubMed PubMed Citation Articles by Gays, F. Articles by Brooks, C. G. Pubmed/NCBI databases Substance via MeSH

Functional Analysis of the Molecular Factors Controlling Qa1-Mediated Protection of Target Cells from NK Lysis¹

Frances Gays^*, Karen P. Fraser^*, Jennifer A. Toomey^*, Austin G. Diamond^*, Margaret M. Millrain, P. Julian Dyson and Colin G. Brooks^2,*

^* Department of Microbiology and Immunology, The Medical School, Newcastle, United Kingdom; and The Transplantation Biology Unit, Medical Research Council Clinical Sciences Centre, London, United Kingdom

CD94/NKG2 receptors on mouse NK cells recognize the nonclassical class I molecule Qa1 and can deliver inhibitory signals that prevent NK cells from lysing Qa1-expressing cells. However, the exact circumstances under which Qa1 protects cells from NK lysis and, in particular, the role of the dominant Qa1-associated peptide, Qdm, are unclear. In this study, we examined in detail the lysis of Qa1-expressing cells by fetal NK cells that express CD94/NKG2 receptors for Qa1 but that lack receptors for classical class I molecules. Whereas mouse L cells and human C1R cells transfected with Qa1 were resistant to lysis by these effectors, Qa1-transfected TAP-deficient human T2 cells showed no resistance despite expressing high levels of surface Qa1. However, these cells could be efficiently protected by exposure to low concentrations of Qdm peptide or certain Qdm-related peptides. By contrast, even prolonged exposure of TAP-deficient RMA/S cells to high doses of Qdm peptide failed to induce levels of surface Qa1 detectable with a Qa1-specific mAb or to protect them from NK lysis, although such treatment induced sensitivity to lysis by Qa1-specific CTL. Collectively, these findings indicate that high surface expression of Qa1 is necessary but not sufficient for protection, and that effective protection requires the expression of sufficient levels of suitable Qa1-peptide complexes to overcome activatory signals. Results obtained with a series of substituted Qdm peptides suggest that residues at positions 3, 4, 5, and 8 of the Qdm sequence, AMAPRTLLL, are important for recognition of Qa1-Qdm complexes by inhibitory CD94/NKG2 receptors.

This article has been cited by other articles:

				W. Chen, L. Zhang, B. Liang, Y. Saenger, J. Li, L. Chess, and H. Jiang Perceiving the avidity of T cell activation can be translated into peripheral T cell regulation PNAS, December 18, 2007; 104(51): 20472 - 20477. [Abstract] [Full Text] [PDF]

				F. Gays, K. Martin, R. Kenefeck, J. G. Aust, and C. G. Brooks Multiple Cytokines Regulate the NK Gene Complex-Encoded Receptor Repertoire of Mature NK Cells and T Cells J. Immunol., September 1, 2005; 175(5): 2938 - 2947. [Abstract] [Full Text] [PDF]

				S. L. Wooden, S. R. Kalb, R. J. Cotter, and M. J. Soloski Cutting Edge: HLA-E Binds a Peptide Derived from the ATP-Binding Cassette Transporter Multidrug Resistance-Associated Protein 7 aSnd Inhibits NK Cell-Mediated Lysis J. Immunol., August 1, 2005; 175(3): 1383 - 1387. [Abstract] [Full Text] [PDF]

				T. Kambayashi, J. R. Kraft-Leavy, J. G. Dauner, B. A. Sullivan, O. Laur, and P. E. Jensen The Nonclassical MHC Class I Molecule Qa-1 Forms Unstable Peptide Complexes J. Immunol., February 1, 2004; 172(3): 1661 - 1669. [Abstract] [Full Text] [PDF]

				A. Tajima, T. Tanaka, T. Ebata, K. Takeda, A. Kawasaki, J. M. Kelly, P. K. Darcy, R. E. Vance, D. H. Raulet, K. Kinoshita, et al. Blastocyst MHC, a Putative Murine Homologue of HLA-G, Protects TAP-Deficient Tumor Cells from Natural Killer Cell-Mediated Rejection In Vivo J. Immunol., August 15, 2003; 171(4): 1715 - 1721. [Abstract] [Full Text] [PDF]

				J. D. Miller, D. A. Weber, C. Ibegbu, J. Pohl, J. D. Altman, and P. E. Jensen Analysis of HLA-E Peptide-Binding Specificity and Contact Residues in Bound Peptide Required for Recognition by CD94/NKG2 J. Immunol., August 1, 2003; 171(3): 1369 - 1375. [Abstract] [Full Text] [PDF]

				A. Davies, S. Kalb, B. Liang, C. J. Aldrich, F. A. Lemonnier, H. Jiang, R. Cotter, and M. J. Soloski A Peptide from Heat Shock Protein 60 Is the Dominant Peptide Bound To Qa-1 in the Absence of the MHC Class Ia Leader Sequence Peptide Qdm J. Immunol., May 15, 2003; 170(10): 5027 - 5033. [Abstract] [Full Text] [PDF]

				J. Michaelsson, C. Teixeira de Matos, A. Achour, L. L. Lanier, K. Karre, and K. Soderstrom A Signal Peptide Derived from hsp60 Binds HLA-E and Interferes with CD94/NKG2A Recognition J. Exp. Med., December 2, 2002; 196(11): 1403 - 1414. [Abstract] [Full Text] [PDF]

				K. Van Beneden, A. De Creus, F. Stevenaert, V. Debacker, J. Plum, and G. Leclercq Expression of Inhibitory Receptors Ly49E and CD94/NKG2 on Fetal Thymic and Adult Epidermal TCR V{gamma}3 Lymphocytes J. Immunol., April 1, 2002; 168(7): 3295 - 3302. [Abstract] [Full Text] [PDF]